Team publications
Articles scientifiques [2023]
The contribution of endocytosis to sensitization of nociceptors and synaptic transmission in nociceptive circuits
Tonello R, Anderson WB, Davidson S, Escriou V, Yang L, Schmidt BL, Imlach WL, Bunnett NW
Pain, 2022, in press > doi: 10.1097/j.pain.0000000000002826
The contribution of endocytosis to sensitization of nociceptors and synaptic transmission in nociceptive circuits
Tonello R, Anderson WB, Davidson S, Escriou V, Yang L, Schmidt BL, Imlach WL, Bunnett NW
Pain, 2022, in press > doi: 10.1097/j.pain.0000000000002826
2023, 164:1355-1374
Development and Application of an Assay to Evaluate the Anti-Parasitic Effect of Humoral Responses against Trypanosoma cruzi.
Martinez-Peinado N, Gabaldon-Figueira JC, Martinez-Añon I, Rodríguez-Gordo C, Robleda-Castillo R, Pinazo MJ, Bigey P, Gascon J, Alonso-Padilla J.
Microorganisms, 2023, 11(2):241 > doi: 10.3390/microorganisms11020241
Integrated omics approach for the identification of HDL structure-function relationships in PCSK9-related familial hypercholesterolemia.
Darabi M, Lhomme M, Ponnaiah M, Pučić-Baković M, Guillas I, Frisdal E, Bittar R, Croyal M, Matheron-Duriez L, Poupel L, Bonnefont-Rousselot D, Frere C, Varret M, Krempf M, Cariou B, Lauc G, Guerin M, Carrie A, Bruckert E, Giral P, Le Goff W, Kontush A.
J Clin Lipidol, 2023, in press > doi: 10.1016/j.jacl.2023.07.003
In Silico and In Vivo Studies of a Tumor-Penetrating and Interfering Peptide with Antitumoral Effect on Xenograft Models of Breast Cancer.
Marin GH, Murail S, Andrini L, Garcia M, Loisel S, Tuffery P, Rebollo A.
Pharmaceutics, 2023, 15(4):1180 > doi: 10.3390/pharmaceutics15041180
Articles scientifiques [2022]
Isolation of Primary Hepatocytes for Testing Tumor Penetrating Peptides
Savier E, Tuffery P, Bruzzoni-Giovanelli H, Rebollo A
Methods Mol Biol, 2022, 2383: 413-427 > doi: 10.1007/978-1-0716-1752-6_26
Molecular mechanisms in Alzheimer’s disease and related potential treatments such as structural target convergence of antibodies and simple organic molecules
Oumata N, Lu K, Teng Y, Cavé C, Peng Y, Galons H, Roques BP
Eur J Med Chem, 2022, 240: 114578 > doi: 10.1016/j.ejmech.2022.114578
Binding and Kinetic Analysis of Human Protein Phosphatase PP2A Interactions with Caspase 9 Protein and the Interfering Peptide C9h
Dorgham K, Murail S, Tuffery P, Savier E, Bravo J, Rebollo A
Pharmaceutics, 2022, 14: 2055 > doi: 10.3390/pharmaceutics14102055
Burden of liver disease progression of patients with type-2 diabetes: a retrospective longitudinal cohort study
Mallet V, Parlati L, Martinino A, Scarano Pereira JP, Navas Jimenez C, Sakka M, Bouam S, Retbi A, Meritet J-F, Thabut D, Rufat P, Bonnefont-Rousselot D, Sogni P, Pol S, Tsochatzis E, for the Demosthenes research group.
J Hepatol, 2022, 76: 265-274 > doi: 10.1016/j.jhep.2021.09.030
Combination of thermal ablation by focused ultrasound, pFAR4-IL-12 transfection and lipidic adjuvant provide a distal immune response
Do HD, Marie C, Bessoles S, Dhotel H, Seguin J, Larrat B, Doan BT, Scherman D, Escriou V, Hacein-Bey-Abina S, Mignet N
Explor Target Antitumor Ther, 2022, 3: 398-413 > doi: 10.37349/etat.2022.00090
Preclinical Validation of Tumor-Penetrating and Interfering Peptides against Chronic Lymphocytic Leukemia
Simón-Gracia L, Loisel S, Sidorenko V, Scodeller P, Parizot C, Savier E, Haute T, Teesalu T, Rebollo A
Mol Pharm, 2022, 19 : 895-903 > doi: 10.1021/acs.molpharmaceut.1c00837
Extracellular vesicle-mediated metastasis suppressors NME1 and NME2 modify lipid metabolism in fibroblasts
Matyasi B, Petovari G, Danko T, Butz H, Liko I, Low P, Petit I, Bittar R, Bonnefont-Rousselot D, Farkas Z, Szeniczey T, Molnar K, Paloczi K, Buzas EI, Boissan M, Sebestyen A, Takacs-Vellai K
Cancers, 2022, 14: 3913 > doi: 10.3390/cancers14163913
Computer-Aided Analysis of West Sub-Saharan Africa Snakes Venom towards the Design of Epitope-Based Poly-Specific Antivenoms
Ros-Lucas A, Bigey P, Chippaux JP, Gascón J, Alonso-Padilla J
Toxins (Basel), 2022, 14: 418 > doi: 10.3390/toxins14060418
PEPscan: A Broad Spectrum Approach for the Characterization of Protein-Binder Interactions?
Rebollo A, Fliedel L, Tuffery P
Biomolecules, 2022, 12: 178 > doi: 10.3390/biom12020178
Spheroplexes: Hybrid PLGA-cationic lipid nanoparticles, for in vitro and oral delivery of siRNA
Arruda DC, Lachagès AM, Demory H, Escriou G, Lai-Kuen R, Dugas PY, Hoffmann C, Bessoles S, Sarrabayrouse G, Malachias A, Finet S, Gastelois PL, de Almeida Macedo WA, da Silva Cunha A Jr, Bigey P, Escriou V
J Control Release, 2022, 350: 228-243 > doi: 10.1016/j.jconrel.2022.08.030
For the 2nd year running, UTCBS is hosting a delegation of South African researchers as part of a bilateral PHC
For the 2nd year running, UTCBS is hosting a delegation of South African researchers as part of a bilateral PHC
CNRS honors Néovacs and UTCBS, united for a therapeutic RNA vaccine against asthma
Suresnes, August 29, 2024 - 8am CET - Neovacs (Euronext Growth Paris : ALNEV), a preclinical-stage biopharmaceutical company developing novel therapies for inflammatory and autoimmune diseases, is honored to be listed among the latest CNRS publications following the...
Publication in Advanced Science of Preclinical tests obtained with a pFAR plasmid
Gene Electrotransfer via Conductivity-Clamped Electric Field Focusing Pivots Sensori-Motor DNA Therapeutics: “A Spoonful of Sugar Helps the Medicine Go Down” https://doi.org/10.1002/advs.202401392
Khair Alareth, Caroline Roques and Nasir Arafath with Nathalie Mignet to present UTCBS’s work at the Controlled release society international congress in Bologna.
UTCBS presents its work at the international congress of the "controlled release society" in Bologna. The UTCBS team has shown the interest of nanoparticles both for the imaging of ROS in vivo and the promotion of antioxydant therapeutic activity. Caroline Roques...